family over here so quickly, you have to grant we wouldn’t be where we are if it hadn’t been for their input.
But you’re right. Continuing to allow their participation is like playing with fire, and it has to change. I spoke with Michael earlier about this very issue before Satoshi arrived, and he and I are going to meet in his office tomorrow mid-morning. He understands and agrees. I told him that as of today, his clients’ role has to revert back to their being silent investors, nothing more. We can offer some stock options to make them fade away.”
Carl raised his eyebrows, doubtful it would be so simple, but didn’t respond.
Satoshi had come over to say good-bye and excuse himself from the party. “I want to get home to my family and give them the good news,” he said, bowing collectively to both Ben and Carl.
“We understand perfectly,” Ben said, exchanging a high-five with the diminutive and youthful-appearing researcher. When Ben had first met him he thought he was in his teens instead of his middle thirties. “Did you get a chance to meet with Pauline about those wills and trust documents?”
“I did and signed them all.”
“Terrific,” Ben said, exchanging another high-five. Satoshi had gotten his Ph.D.
at Harvard and was well versed in American customs. After another round of handshakes, mutual congratulations, and promises to get together socially, Satoshi turned to leave, only to return after just a few steps.
“One thing I wanted to ask,” Satoshi said, looking directly at Ben. “Have you been able to make any progress on finding me lab access?” Still in its infancy, iPS
USA was merely office space in the building on Fifth Avenue. It had no research facilities of its own and probably never would. Its business plan was to take advantage of the chaos associated with patents involving stem cells in general 17
and induced pluripotent stem cells in particular. The idea was to corner the stem cell market by controlling the intellectual property associated with other people’s discoveries, and to do it before others knew what iPS USA was up to: a kind of intellectual-property blitzkrieg.
“Not yet,” Ben admitted. “But I believe I’m making progress up at Columbia Medical Center to rent some space in their new stem cell building. We should hear any day now. Stop in or give a call tomorrow! I’ll phone up there first thing in the morning.”
“Thank you,” Satoshi said while bowing. “I am very happy.”
“Keep in touch!” Ben said, giving the smaller man a friendly slap on the shoulder.
“Hai, hai,” Satoshi replied, and continued out.
“Research space?” Carl questioned after Satoshi left the room.
“He’s yearning for some bench time,” Ben said. “He feels a little like a fish out of water when he’s away from the lab.”
“I have to say, you guys have hit it off.”
“I suppose,” Ben said vaguely. “Jacqueline and I have taken him and his wife out to dinner a couple of times here in the city. He’s got a little boy, a year and a half old. I tell you, the kid doesn’t even look real, and he’s silent. Not a sound.
He just looks around with these huge eyes as if he’s taking it all in.”
“What is he going to do in the laboratory?” Carl questioned, ever the bean counter. “Isn’t that going to be expensive?”
“He wants to work on electroporation techniques for iPS generation,” Ben said with a shrug. “I don’t know exactly, nor do I particularly care. What I do care about is keeping him happy, which is why we rushed to get him and his family into the States ASAP, without waiting for formalities to be completed. He’s a real researcher at heart and considers all the legal negotiations a waste of time. We don’t want him straying and changing his mind until we get everything completely buttoned up, patentwise. He’s going to be our golden goose, but only if we keep him contentedly in the nest.”
“So, right now,
Lexy Timms, B+r Publishing, Book Cover By Design